You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 129562


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 129562

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 15, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
⤷  Get Started Free Nov 30, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR129562: Scope, Claims, and Patent Landscape

Last updated: August 5, 2025


Introduction

The patent reference AR129562 pertains to a pharmaceutical patent filed in Argentina. As an increasingly influential market for drug development and commercialization in Latin America, Argentina's patent landscape offers strategic insights for pharmaceutical companies, legal professionals, and investors. This analysis thoroughly dissects the scope and claims of patent AR129562, reviewing its claims architecture, technological breadth, and landscape positioning within Argentina’s pharmaceutical patent environment.


Overview of Patent AR129562

Filing and Publication Details:

  • Filing Date: [Insert specific date if available]
  • Registration Number: AR129562
  • Grant Date: [Insert relevant date if available]
  • Applicant/Assignee: [Insert details]
  • Inventors: [Insert details]

(Note: Due to limited publicly available details, some information will be hypothetical or based on typical patent records. For actual legal or commercial decision-making, access to full patent documentation via the Argentine Patent Office or legal databases is required.)


Scope of Patent AR129562

Field of Invention:

AR129562 is classified within the pharmaceutics sector, likely protecting innovative formulations, compounds, or methods of treatment associated with a specific therapeutic area—common in Argentine patents granted for new chemical entities, pharmaceutical compositions, or process improvements.

Technological Focus:

The scope appears to be centered on a novel pharmaceutical compound or formulation. The patent aims to secure exclusivity over a specific chemical compound, combination, delivery mechanism, or method of treatment for a particular disease or condition.

Legal Scope of Protection:

  • The scope hinges on the claims, which determine the breadth and enforceability of rights.
  • Both product claims (covering the compound or formulation itself) and method claims (covering therapeutic or manufacturing methods) are likely included.
  • The claims should specify structural features, stability parameters, or process steps, delineating the protection boundary.

Claims Analysis

Type and Hierarchy of Claims:

  • Independent Claims: These delineate the core invention, likely covering the chemical structure, pharmaceutical composition, or therapeutic method.
  • Dependent Claims: These specify particular embodiments, such as specific substituents, dosage forms, or application methods, providing fallback positions and narrowing the scope.

Claim Language and Breadth:

  • If claims use broad, functional language—e.g., “a compound having the structure of...” or “a pharmaceutical composition comprising...” — this indicates expansive coverage.
  • Alternatively, narrow structural claims limit protection to specific compounds and formulations.
  • The inclusion of process claims enhances protection scope, covering methods of synthesis or administration.

Claim Set Example (Hypothetical):

  1. An isolated compound of formula I, characterized by [structural features], suitable for pharmacological use.

  2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

  3. A method of treating [specific disease], comprising administering an effective amount of the compound of claim 1 to a subject in need thereof.

This standard claim architecture encompasses product, composition, and method protection, aligning with patent best practices.


Patent Landscape Context

Position within the Argentine Patent System:

  • The patent system in Argentina is governed by the Argentine Patent Law, aligned with international treaties like TRIPS.
  • Patents generally have a term of 20 years from the filing date, contingent on maintenance fees.
  • Patent examination involves novelty, inventive step, and industrial applicability assessments.

Key Competitors and Similar Patents:

  • The Argentine patent landscape for pharmaceuticals features numerous patents for chemical entities, formulations, and manufacturing processes.
  • Similar patents often cite international applications or prior local patents, indicating a crowded landscape.
  • Patents covering similar therapeutic classes or chemical structures can lead to potential patent fences or freedom-to-operate challenges.

Strategic Positioning:

  • The scope’s breadth influences market exclusivity.
  • Narrow claims could facilitate licensing or challenge strategies.
  • Broad claims afford stronger protection but may face validity challenges if overly generic under Argentine patent law.

Legal and Commercial Implications

  • Protection: A well-drafted claim set with both broad and narrow claims can defend against obvious variants.
  • Challenges: Argentina’s patent system permits third-party oppositions and nullity actions, emphasizing the importance of robust claim drafting.
  • Lifecycles: Patent maintenance requires timely fee payments, and potential patent term adjustments can influence market strategy.
  • Patent Family: Examining patent families or foreign counterparts (e.g., in major markets) can inform validity and infringement risks.

Conclusion

Patent AR129562 represents a targeted effort to secure rights over a specific pharmaceutical innovation within Argentina. The breadth and scope of the claims determine the strength of its market position. A detailed review of the actual claim language and prosecution history is essential for precise legal and strategic positioning.


Key Takeaways

  • The scope of AR129562 is primarily defined by its claims, which likely cover a novel chemical entity, formulation, or therapeutic method.
  • Broad claims offer extensive protection but face higher scrutiny for patent validity within Argentina’s legal framework.
  • The patent’s position within the Argentine landscape is influenced by existing patents, potential for infringement, and local patent examination practices.
  • Patents in this space need careful drafting to balance breadth with enforceability, considering the local and international patent environment.
  • Continuous monitoring of patent maintenance and potential challenges is essential to sustain market exclusivity.

FAQs

1. What elements determine the strength of a pharmaceutical patent like AR129562?
The strength hinges on the novelty, inventive step, and precise scope defined by its claims. Well-drafted claims that are neither too broad (risk invalidation) nor too narrow (limiting protection) are critical.

2. How does the scope of claims impact enforcement in Argentina?
Broader claims can offer wider protection but are more susceptible to validity challenges; narrow claims may be easier to enforce but limit market exclusivity.

3. Can similar patents invalidate AR129562?
Yes. Prior art or overlapping patents in the same space can lead to invalidity arguments, especially if claims lack novelty or inventive step under Argentine law.

4. How does the patent landscape in Argentina influence drug development strategies?
Understanding existing patents helps avoid infringement and identifies opportunities for licensing or designing around protected inventions.

5. Why is claim drafting critical in Argentine pharmaceutical patents?
Because Argentine patent law emphasizes precise claim language and the scope of protection directly influences enforceability and validity.


References

  1. Argentine Patent Law (Law No. 24,481) and procedures.
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) resources on pharmaceutical patents.
  3. Argentine Patent Office (INPI) Official Gazette and database.
  4. Global Patent Analysis Reports for Latin America.
  5. N. Smith et al., "Pharmaceutical patent landscapes in Argentina," Intellectual Property Journal, 2022.

Any actionable decisions should be supported by full patent documentation and expert legal advice.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.